Godrej Agrovet Ltd (BOM:540743)
₹ 579.05 +17.65 (+3.14%) Market Cap: 111.39 Bil Enterprise Value: 125.36 Bil PE Ratio: 24.94 PB Ratio: 5.48 GF Score: 86/100

Q1 2027 Godrej Agrovet Ltd Earnings Call Transcript

Aug 6, 2026 / 10:00 AM GMT
Release Date Price: ₹545.45 (-3.80%)

Key Points

Positve
  • Godrej Agrovet Ltd (NSE:GODREJAGRO) delivered consolidated sales growth of 10% YoY to Rs 2,852 crore, despite a challenging environment with a delayed monsoon and geopolitical inflationary pressures.
  • The Animal Nutrition business posted a strong quarter with 12.6% revenue growth, driven by a 15% increase in cattle feed volumes and a 36% rise in underlying segment results, reflecting strategic sourcing and cost discipline.
  • The Oil Palm business continued its momentum with 28.9% revenue growth, supported by higher CPO/PKO realizations, improved oil extraction rates (OER up to 18.8%), and a robust area expansion plan targeting a doubling of hectares to 150,000.
  • Aztec Life Sciences sustained its operational recovery, reaching EBITDA breakeven compared to an INR 11 crore loss in Q1 FY26, with management raising its full-year revenue growth guidance to over 20%.
  • The Dairy business achieved 11.4% revenue growth with value-added product salience increasing from 42% to 49%, while the branded B2C food business (Yummy's) saw volumes surge 22%, with the B2C segment growing at 28%.
  • The Bangladesh joint venture (ACI Godrej Agrovet) returned to a strong growth trajectory with double-digit growth in volumes, revenue, and PBT, supported by broad-based expansion and operating leverage.
Negative
  • The standalone Crop Care business was severely impacted by a significantly delayed monsoon and slower Kharif sowing, leading to a 16.2% decline in segment revenue and margin contraction, particularly in the in-house cotton herbicide segment.
  • The Dairy business profitability was negatively affected by elevated milk procurement prices due to industry-wide supply constraints and inflation in other inputs, with management expecting these high prices to persist for another 2-3 quarters.
  • Godrej Foods' overall profitability was hurt by higher input costs and inflationary pressures from geopolitical disruptions, which were only partially offset by pricing actions, masking the strong performance of its B2C branded portfolio.
  • The Oil Palm business experienced a marginal decline in segment margins (from 19% to 17%) due to a flattish FFB volume against a strong comparable quarter and government pricing formula changes, despite higher realizations.
  • The company's overall PBT growth guidance for FY27 has been tempered from mid-teens to a more cautious double-digit target, with management citing uncertainty around the extent of Crop Care recovery and the impact of geopolitical events like the Middle East war on packaging costs.
  • The planned strategic reduction in livebird volumes within Godrej Foods is expected to continue, causing a drag on overall reported revenue growth for the segment over the next 3-4 years.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GODE.NS - Godrej Agrovet Ltd
Q1 2027 Godrej Agrovet Ltd Earnings Call
Aug 06, 2026 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and Gentlemen, Good day and welcome to the Godrej Agrovate Ltd Q1 FY27 Earnings Conference Call hosted by Anand Rathi. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during this conference call, please signal an operator by pressing *, then 0 on your touchstone phone. Please note that this conference is being recorded.

I now hand the conference over to Mr. Nitesh Dutt from Anandrathi.

Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot